Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Eosinophilic Cystitis

A Rare Inflammatory Pathology Mimicking Bladder Neoplasms

Kiliç S.a · Erguvan R.b · Ipek D.a · Gökçe H.b · Güneş A.a · Aydin N.E.b · Baydinç C.a

Author affiliations

Departments of aUrology and bPathology, Inonu University Medical Faculty, Turgut Özal Medical Center, Malatya, Turkey

Related Articles for ""

Urol Int 2003;71:285–289

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 28, 2002
Accepted: November 06, 2002
Published online: September 30, 2003
Issue release date: October 2003

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Purpose: We present a large series of eosinophilic cystitis including 8 cases; 3 of them had tumor-like lesions. Materials and Methods: The archives of pathology clinic of Inonu University Medical Faculty were reviewed from 1988 to 2002. The characteristics of patients and their diseases were recorded. Data obtained from 180 cases (172 from the literature and 8 from the present series) was assessed. Results: Seven cases had symptoms such as dysuria, frequency, hematuria, suprapubic pain, and difficulty in voiding. One asymptomatic case with history of bladder carcinoma was diagnosed during routine cystoscopy. The findings were microhematuria in 6 cases, macrohematuria in 2, pyuria in 3, urinary infection in 1, eosinophilia in 1, hyperazotemia in 1, and bladder masses in 3. Cystoscopies detected edematous and erythematous areas in 5 cases and lesions mimicking bladder carcinoma in 3. One case did not take further treatment after cystoscopy and biopsy and completely recovered. Four cases underwent medical therapy with nonsteroidal anti-inflammatory drugs and antihistaminics. They became asymptomatic and control cystoscopies showed no abnormal finding. Two of three patients with mass lesions recovered after steroid therapy following transurethral resection. The lesion in the third recurred and he improved after a second course of steroid therapy. Conclusions: Eosinophilic cystitis is a rare pathology. Sometimes, it may simulate bladder malignancies. Biopsy is mandatory at diagnosis. Usually, it has a benign course and may be treated with fulguration, analgesics, antihistaminics and steroids, although recurrence is possible.

© 2003 S. Karger AG, Basel


References

  1. Brown EW: Eosinophilic granuloma of the bladder. J Urol 1960;83:665–668.
  2. Palubinskas AJ: Eosinophilic cystitis: Case report of eosinophilic infiltration of the urinary bladder. Radiology 1960;75:589.
  3. Van den Ouden D: Diagnosis and management of eosinophilic cystitis: A pooled analysis of 135 cases. Eur Urol 2000;37:386–394.
  4. Verhagen P, Nikkels P, de Jong T: Eosinophilic cystitis. Arch Dis Child 2001;84:344–346.
    External Resources
  5. Itano NMB, Malek RS: Eosinophilic cystitis in adults. J Urol 2001;165:805–807.
  6. Van den Ouden D, van Kaam N, Eland D: Eosinophilic cystitis presenting as urinary retention. Urol Int 2001;66:22–26.
  7. Sibert L, Khalaf A, Bugel H, Sfaxi M, Grise P: Intravesical dimethylsulfoxide instillations can be useful in the symptomatic treatment of profuse hematuria due to eosinophilic cystitis. J Urol 2000;164:446–448.
  8. Pomeranz A, Elikaim A, Uziel Y, Gottesman G, Rathaus V, Zehavi T, Wolach B: Eosinophilic cystitis in a 4-year-old boy: Successful long-term treatment with cyclosporin A. Pediatrics 2001;108:E113.
    External Resources
  9. Göğüş C, Türkölmez K, Tolunay O, Göğüş O: Eosinophilic cystitis in a case with an initial diagnosis of invasive bladder tumor. Urol Int 2000;64(3):162–164.
  10. Kayigil O, Özbaği T, Çakar S, Metin A: Contracted bladder secondary to eosinophilic cystitis. Int Urol Nephrol 2001;33:341–342.
  11. Lin HY, Chou YH, Wu WJ, Huang CH, Chai CY: Eosinophilic cystitis: Eight case reports and literature review. Kaohsiung J Med Sci 2002;18:30–34.
  12. Clark T, Chang SS, Cookson MS: Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin-C therapy. J Urol 2002;167:1795.
  13. Reuter VE, Melamed MR: The urothelial tract: renal pelvis, ureter, urinary bladder and urethra; in Sternberg SS (ed): Diagnostic Surgical Pathology, ed 3. China, Lippincott Williams and Wilkins, 1999, vol 2, pp 1853–1891.
  14. Dubucquoi S, Janin A, Desreumaux P, Rigot JM, Copin MC, Francois M, Torpier G, Capron M, Gosselin B: Evidence for eosinophils activation in eosinophilic cystitis. Eur Urol 1994;25:254–258.
  15. Sano K, Terashima K, Gotoh K, Ijiri R, Tanaka Y: A case of eosinophilic cystitis in a 5-year-old boy. Int J Urol 2000;7:54–56, discussion 57.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 28, 2002
Accepted: November 06, 2002
Published online: September 30, 2003
Issue release date: October 2003

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.